332 related articles for article (PubMed ID: 35011388)
1. Cannabinoids in Breast Cancer: Differential Susceptibility According to Subtype.
Almeida CF; Teixeira N; Correia-da-Silva G; Amaral C
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011388
[TBL] [Abstract][Full Text] [Related]
2. Unveiling the mechanism of action behind the anti-cancer properties of cannabinoids in ER
Amaral C; Trouille FM; Almeida CF; Correia-da-Silva G; Teixeira N
J Steroid Biochem Mol Biol; 2021 Jun; 210():105876. PubMed ID: 33722705
[TBL] [Abstract][Full Text] [Related]
3. Future Aspects for Cannabinoids in Breast Cancer Therapy.
Kisková T; Mungenast F; Suváková M; Jäger W; Thalhammer T
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987191
[TBL] [Abstract][Full Text] [Related]
4. Phytocannabinoids in Triple Negative Breast Cancer Treatment: Current Knowledge and Future Insights.
Bimonte S; Palma G; Cascella M; Cuomo A
Anticancer Res; 2023 Mar; 43(3):993-1000. PubMed ID: 36854495
[TBL] [Abstract][Full Text] [Related]
5. The Endocannabinoid System: A Target for Cancer Treatment.
Laezza C; Pagano C; Navarra G; Pastorino O; Proto MC; Fiore D; Piscopo C; Gazzerro P; Bifulco M
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979368
[TBL] [Abstract][Full Text] [Related]
6. The use of cannabinoids in multiple sclerosis.
Teare L; Zajicek J
Expert Opin Investig Drugs; 2005 Jul; 14(7):859-69. PubMed ID: 16022575
[TBL] [Abstract][Full Text] [Related]
7. Medical Use of Cannabinoids.
Fraguas-Sánchez AI; Torres-Suárez AI
Drugs; 2018 Nov; 78(16):1665-1703. PubMed ID: 30374797
[TBL] [Abstract][Full Text] [Related]
8.
Stasiłowicz A; Tomala A; Podolak I; Cielecka-Piontek J
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466734
[No Abstract] [Full Text] [Related]
9. Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas.
Fraguas-Sánchez AI; Fernández-Carballido A; Torres-Suárez AI
Expert Opin Investig Drugs; 2016 Nov; 25(11):1311-1323. PubMed ID: 27633508
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoids in the treatment of cancer.
Alexander A; Smith PF; Rosengren RJ
Cancer Lett; 2009 Nov; 285(1):6-12. PubMed ID: 19442435
[TBL] [Abstract][Full Text] [Related]
11. Endocannabinoid System: A Multi-Facet Therapeutic Target.
Kaur R; Ambwani SR; Singh S
Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
[TBL] [Abstract][Full Text] [Related]
12. Breast Cancer: Current Molecular Therapeutic Targets and New Players.
Nagini S
Anticancer Agents Med Chem; 2017; 17(2):152-163. PubMed ID: 27137076
[TBL] [Abstract][Full Text] [Related]
13. Phytocannabinoids and endocannabinoids.
Fisar Z
Curr Drug Abuse Rev; 2009 Jan; 2(1):51-75. PubMed ID: 19630737
[TBL] [Abstract][Full Text] [Related]
14. Combined antiproliferative effects of the aminoalkylindole WIN55,212-2 and radiation in breast cancer cells.
Emery SM; Alotaibi MR; Tao Q; Selley DE; Lichtman AH; Gewirtz DA
J Pharmacol Exp Ther; 2014 Feb; 348(2):293-302. PubMed ID: 24259678
[TBL] [Abstract][Full Text] [Related]
15. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
Melck D; De Petrocellis L; Orlando P; Bisogno T; Laezza C; Bifulco M; Di Marzo V
Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630
[TBL] [Abstract][Full Text] [Related]
16. Cellular approaches to the interaction between cannabinoid receptor ligands and nicotinic acetylcholine receptors.
Oz M; Al Kury L; Keun-Hang SY; Mahgoub M; Galadari S
Eur J Pharmacol; 2014 May; 731():100-5. PubMed ID: 24642359
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators.
Brown I; Cascio MG; Rotondo D; Pertwee RG; Heys SD; Wahle KW
Prog Lipid Res; 2013 Jan; 52(1):80-109. PubMed ID: 23103355
[TBL] [Abstract][Full Text] [Related]
18. Emerging role of cannabinoids and synthetic cannabinoid receptor 1/cannabinoid receptor 2 receptor agonists in cancer treatment and chemotherapy-associated cancer management.
Shah SA; Gupta AS; Kumar P
J Cancer Res Ther; 2021; 17(1):1-9. PubMed ID: 33723124
[TBL] [Abstract][Full Text] [Related]
19. Constituents of Cannabis Sativa.
Rock EM; Parker LA
Adv Exp Med Biol; 2021; 1264():1-13. PubMed ID: 33332000
[TBL] [Abstract][Full Text] [Related]
20. Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities.
Lal S; Shekher A; Puneet ; Narula AS; Abrahamse H; Gupta SC
Pharmacol Res; 2021 Jan; 163():105302. PubMed ID: 33246167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
